000			01676nam a22002417a 4500
999			_c7952 _d7952
001			5005
003			PILC
005			20240720152606.0
008			160505b2012 xxu||||| |||| 00| 0 eng d
040			_cFEU-NRMF MEDICAL LIBRARY
041			_aEnglish
050			_aRES OB-GYNE 2012 0001
100			_aAcada, Hanna N., M.D.
245			_aAntiphospholipid Antibody Syndrome, Myasthenia Gravis, and Diabetes Mellitus: A Mosaic of Autoimmune Entities in A Pregnant Patient
264		0	_c2012
336			_aText
337			_aUnmediated
338			_aVolume
502			_bMEDICINE _gResearch project
520			_aThis is a case of a 34-year old, Gravida 5 Para 0 (0040), Pregnancy Uterine 36 weeks, in breech presentation, who presented with poor obstetrical history, she was diagnosed with Antiphospholipid antibody Syndrome. Myasthenia Gravis, and Gestational Diabetes Mellitus-Insulin requiring, and was admitted due to preterm labor. The patient was given the standard management for these clinical entities. For APAS low molecular weight and low dose aspirin, for myasthenia Gravis Pyridostigmine, and for Gestational Diabetes Mellitus, fetal suerveillance via weekly BPS and NST, CBG monitoring, and insulin. The patient was tocolysed with calcium channel blocker (Nifedine) until she reach 38 weeks wherein she then underwent low segment cesarean section which resulted to ag ood baby outcome. APAS and Myasthenia Gravis, the two being autoimmune in origin, are due to the presence of autoantiboides. Therefore the possibilility that her Gestational Diabetes Mellitus could also be of autoimmune origin was considered.
887			_aRES RC00370
942			_2lcc _cRE